Impact of KRAS Mutations and Co-Alterations on Outcomes in Stage III Nonsquamous NSCLC Treated With Chemoradiation and Immunotherapy.

Saved in:
Bibliographic Details
Title: Impact of KRAS Mutations and Co-Alterations on Outcomes in Stage III Nonsquamous NSCLC Treated With Chemoradiation and Immunotherapy.
Authors: Mankuzhy NP; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York., Santo V; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Shin JY; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York., Chaunzwa TL; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York., Gelblum DY; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York., Wu AJ; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York., McMillan MT; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York., Ma J; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York., Billing D; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York., Iyengar P; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York., Simone CB 2nd; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York; New York Proton Center, New York, New York., Offin M; Thoracic Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, New York., Schoenfeld AJ; Thoracic Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, New York., Arbour KC; Thoracic Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, New York., Alessi J; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Pecci F; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Garbo E; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Gariazzo E; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Awad MM; Thoracic Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, New York., Gomez DR; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York., Chaft JE; Thoracic Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, New York., Ricciuti B; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Shaverdian N; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York. Electronic address: shaverdn@mskcc.org.
Source: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer [J Thorac Oncol] 2026 Jun; Vol. 21 (6), pp. 103565. Date of Electronic Publication: 2026 Jan 29.
Publication Type: Journal Article; Multicenter Study
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 101274235 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1556-1380 (Electronic) Linking ISSN: 15560864 NLM ISO Abbreviation: J Thorac Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1556-1380
DOI:10.1016/j.jtho.2026.103565